Team:HKUST-Hong Kong/Assembly

From 2012.igem.org

(Difference between revisions)
 
(18 intermediate revisions not shown)
Line 359: Line 359:
  <div><p align="center"><font size="20">Assembly</font></p></div>
  <div><p align="center"><font size="20">Assembly</font></p></div>
 +
 +
<div><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Parts_and_Device"><<< Back to Parts and Devices</a></p></div>
  <div id="paragraph1" class="bodyParagraphs">
  <div id="paragraph1" class="bodyParagraphs">
            
            
-
           <p><br><font size="1">
+
           <p><br><font size="2">
-
To assembly the three modules together and transform our construct into B. subtilis, an integration plasmid, pDG1661, from BGSC was employed. There are several reasons why we choose to use this vector. <br><br></font>
+
To assemble the three modules together and transform our construct into <em>B. subtilis</em>, an integration plasmid, pDG1661, from BGSC was employed. There are several reasons why we decided to use this vector. <br>
 +
<br></font>
-
<b>1. Plasmid instability in B. subtilis: </b><br>Plasmid instability is a phenomenon observed with recombinant DNA in Gram-positive hosts. Frequently occurred structure alterations and loss of plasmids prompt the study in integration vectors. In our project, we utilize an integration plasmid. The whole construct are inserted into its multiple cloning site and integrated into the B. subtilis genome through homologous recombination. This integration can help stabilize the recombinant DNA and generate relatively genetically stable bacteria.<br><br>
+
<b>1. Plasmid instability in <em>B. subtilis</em>: </b><br>Plasmid instability is a phenomenon observed in DNA recombination with Gram-positive hosts. Frequently occurring structure alterations and loss of plasmids prompted the study in integration vectors. In our project, we utilize an integration plasmid. The whole construct is inserted into its multiple cloning site and integrated into the <em>B. subtilis</em> genome through homologous recombination. This integration can help stabilize the recombinant DNA and generate relatively genetically stable bacteria.<br><br>
-
<b>2.Biosafety: </b><br>In consideration of possible horizontal gene transfer between bacteria within normal flora in gut, integration plasmid is decided to use in order to reduce the chance of plasmid loss and antibiotic resistant gene spreading in gut. <br>
+
<b>2.Biosafety: </b><br>Given the possibility of horizontal gene transfer between bacteria within normal flora in the gut, integration plasmid is used in order to reduce the chance of plasmid loss and the transfer of antibiotic resistant genes to other microflora in gut. <br>
<p align="center">
<p align="center">
<img src="https://static.igem.org/mediawiki/2012/6/6b/UST-pDG1661.png" width="60%" /> </p>
<img src="https://static.igem.org/mediawiki/2012/6/6b/UST-pDG1661.png" width="60%" /> </p>
-
pDG1661, the integration vector we used in our project facilitate the integration through the 5’ and 3’ segment of B. subtilis amyE gene franking at the two end of multiple cloning site. A cat gene encoding chloramphenicol acetyl tranferase is located within the integration area for B. subtilis transformation selection. Containing only a replication origin for E coli, this vector needs to be replicated in E coli first and selected through ampicillin resistance obtaining from the bla gene on this vector. After replication in E coli, the recombinant DNA plasmicd is transformed into B. subtilis and only the one with plasmid integration can survived under chloramphenicol selection, forming colony. The integration can further verified through the starch test. As shown in figure (…), the one without pDG1661 integrated can use starch and surrounded by a white halo after the overnight incubation on LB plate supplemented with starch when gram iodine is adding the next morning. However, since the integration will split amyE gene, the defective B. subtilis can no longer use starch, no white halo can be observed after iodine adding. <br><br>
+
The integration vector we used in our project, pDG1661, facilitates the integration through the 5’ and 3’ segment of <em>B. subtilis</em> <em>amyE</em> gene flanking at the two ends of the multiple cloning site. A <em>cat</em> gene encoding chloramphenicol acetyl tranferase is located within the integration area for <em>B. subtilis</em> transformation selection. Containing only a replication origin for <em>E. coli</em>, this vector needs to be replicated in <em>E. coli</em> first and selected through ampicillin resistance obtaining from the <em>bla</em> gene on this vector. After replication in <em>E. coli</em>, the recombinant DNA plasmid is transformed into <em>B. subtilis</em> and only the ones that have undergone plasmid integration can survived under chloramphenicol selection, forming colonies. The integration can be further verified through the starch test. As shown in the photo below, since the cells without pDG1661 integrated can utilize starch, they are surrounded by a white halo after overnight incubation on a LB plate that has been supplemented with starch. This can be visualized by adding gram iodine after overnight incubation. However, since the integration will split the <em>amyE</em> gene, the defective <em>B. subtilis</em> can no longer use starch, and no white halo can be observed after adding iodine. <br>
 +
<br>
-
<b>3. Final Assembly:</b> <br>The final recombinant DNA plasmid we get is shown in figure (……). Driven by pVeg promoter, RPMrel peptide can be highly expressed and displayed on cell wall after fusing with lytC displaying system. Two protein coding genes, bmp2 and toxin ydcE is under the control of xylose inducible promoter so that after binding, the induction of xylose can trigger the expression toxin and anti-tumor chemokine at the same time. pTms with antitoxin ydcD is then inserted into the same vector as well in order to provide a threshold BMP2 production through its counteracting with toxin ydcE. <br><br>
+
<p align="center">
-
Since pDG1661 is not a standard bio-brick, which contains one xbaI cutting site and three pstI cutting site outside its MCS, we utilize vector pBluescript II KS+ to add BamHI cutting site after PstI as shown in figure (…) and inserting all our construct through EcoRI and BamHI site.<br>
+
<img src="https://static.igem.org/mediawiki/2012/b/bb/HKUST_P1030005.JPG" width="60%" /> </p>
 +
<p align="center">Photo: Starch test for plasmid integration</p>
 +
 
 +
<b>3. Final Assembly:
 +
</b>  
 +
<p align="center"> <img src="https://static.igem.org/mediawiki/2012/0/07/Whole_project.JPG" width="80%" /></p>
 +
 
 +
<br>The final recombinant DNA plasmid we get is shown in Figure above. Driven by <em>Pveg</em> promoter, RPMrel peptides can be highly expressed and displayed on the cell wall after fusing with the <em>lytC</em> displaying system. Two protein coding genes, <em>Bmp2</em> and toxin <em>ydcE</em> are under the control of a xylose inducible promoter <em>PxylA</em> so that after binding, the induction of xylose can trigger the expression of both toxin and anti-tumor chemokine at the same time. <em>Ptms</em>, a weak constitutive promoter coupled with the antitoxin <em>ydcD</em> is then inserted into the same vector as well in order to limit BMP2 production through the need to maintain comparable toxin-antitoxin production rates. <br><br>
 +
Since pDG1661 contains one XbaI cutting site and three PstI cutting sites outside its multiple cloning site, inserts cannot be ligated via standard bio-brick assembly methods. Instead,  we utilize vector pBluescript II KS(+) to add a BamHI cutting site after PstI and inserting all our construct through EcoRI and BamHI site.<br>
Line 386: Line 398:
#paragraph1{
#paragraph1{
-
background-color:#FFFFEE;
+
background-color:#EDFFFF;
width:955px;
width:955px;
height:auto;
height:auto;
Line 400: Line 412:
</style>
</style>
 +
 +
<div id="Sitemap">
 +
<div id="Sitemap_Home" align="center">
 +
<p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong"><b>Home</b></a></p>
 +
</div>
 +
<div class="Sitemap_Content">
 +
<li><p><b>Team</b><p><ol>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Introduction">Introduction</a></p></li>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Supervisor">Supervisor</a></p></li>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Instructor">Instructor</a></p></li>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Members">Members</a></p></li>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Advisors">Advisors</a></p></li>
 +
</ol>
 +
</div>
 +
<div class="Sitemap_Content">
 +
<li><p><b>Project</b></p><ol>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Project_Abstraction">Abstract</a></p></li>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Background_and_Motive">Motive</a></p></li>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Design_Overview">Design - Overview</a></p></li>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Design_Module">Design - Module</a></p></li>
 +
<p>-- <a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Module/Target_binding">Target Binding Module</a></p>
 +
<p>-- <a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Module/Anti_tumor">Anti-tumor Molecule Secretion Module</a></p>
 +
<p>-- <a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Module/Regulation_and_control">Regulation and Control Module</a></p>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Design_Chassis">Design - Chassis</a></p></li></ol>
 +
</div>
 +
<div class="Sitemap_Content">
 +
<li><p><b>Wet Lab</b></p><ol>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Parts_and_Device">Parts and Devices</a></p></li>
 +
<p>-- <a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Parts_and_Device">Overview</a></p>
 +
<p>-- <a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Construction">Construction</a></p>
 +
<p>-- <a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Assembly">Assembly</a></p>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Notebook">Notebook</a></p></li>
 +
<p>-- <a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Notebook/Logbook">Logbook</a></p>
 +
<p>-- <a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Notebook/Protocol">Protocol</a></p>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Characterization">Characterization</a></p></li>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Achievement">Achievement</a></p></li>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Future_Work">Future Work</a></p></li></ol>
 +
</div>
 +
<div class="Sitemap_Content">
 +
<li><p><b>Human Practice</b></p><ol>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Overview">Overview</a></p></li>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Interview">Interview</a></p></li>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Presentation">Presentation</a></p></li>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Calendar">Calendar</a></p></li></ol>
 +
</div>
 +
<div class="Sitemap_Content">
 +
<li><p><b>Extras</b></p><ol>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Medal_Requirements">Medal Requirements</a></p></li>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Safety">Safety</a></p></li>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Attribution">Attribution</a></p></li>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Acknowledgement">Acknowledgement</a></p></li>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Glossary">Glossary</a></p></li></ol>
 +
</div>
 +
</div>
 +
<style type="text/css">
 +
#Sitemap{
 +
background-image:url('https://static.igem.org/mediawiki/2012/c/c0/HKUST_Campus.jpg');
 +
background-color:#ffffff;
 +
width:955px;
 +
height:auto;
 +
float:left;
 +
margin-top:5px;
 +
margin-bottom:5px;
 +
padding-bottom:5px;
 +
padding-top:5px;
 +
padding-left:4px;
 +
border:3px solid #000000;
 +
border-radius:10px;
 +
-moz-border-radius:10px;
 +
}
 +
.Sitemap_Content{
 +
background-color:#ffffff;
 +
opacity:0.8;
 +
width:173px;
 +
height:auto;
 +
float:left;
 +
margin:1px;
 +
padding-bottom:5px;
 +
padding-left:5px;
 +
border:3px solid #000000;
 +
border-radius:10px;
 +
-moz-border-radius:10px;
 +
}
 +
#Sitemap_Home{
 +
background-color:#ffffff;
 +
opacity:0.8;
 +
width:940px;
 +
height:auto;
 +
float:left;
 +
margin:1px;
 +
padding-bottom:5px;
 +
padding-left:5px;
 +
border:3px solid #000000;
 +
border-radius:10px;
 +
-moz-border-radius:10px;
 +
}
 +
</style>
 +
</body>
</body>
</html>
</html>

Latest revision as of 22:36, 26 September 2012

Team:HKUST-Hong Kong - 2012.igem.org

Assembly

<<< Back to Parts and Devices


To assemble the three modules together and transform our construct into B. subtilis, an integration plasmid, pDG1661, from BGSC was employed. There are several reasons why we decided to use this vector.

1. Plasmid instability in B. subtilis:
Plasmid instability is a phenomenon observed in DNA recombination with Gram-positive hosts. Frequently occurring structure alterations and loss of plasmids prompted the study in integration vectors. In our project, we utilize an integration plasmid. The whole construct is inserted into its multiple cloning site and integrated into the B. subtilis genome through homologous recombination. This integration can help stabilize the recombinant DNA and generate relatively genetically stable bacteria.

2.Biosafety:
Given the possibility of horizontal gene transfer between bacteria within normal flora in the gut, integration plasmid is used in order to reduce the chance of plasmid loss and the transfer of antibiotic resistant genes to other microflora in gut.

The integration vector we used in our project, pDG1661, facilitates the integration through the 5’ and 3’ segment of B. subtilis amyE gene flanking at the two ends of the multiple cloning site. A cat gene encoding chloramphenicol acetyl tranferase is located within the integration area for B. subtilis transformation selection. Containing only a replication origin for E. coli, this vector needs to be replicated in E. coli first and selected through ampicillin resistance obtaining from the bla gene on this vector. After replication in E. coli, the recombinant DNA plasmid is transformed into B. subtilis and only the ones that have undergone plasmid integration can survived under chloramphenicol selection, forming colonies. The integration can be further verified through the starch test. As shown in the photo below, since the cells without pDG1661 integrated can utilize starch, they are surrounded by a white halo after overnight incubation on a LB plate that has been supplemented with starch. This can be visualized by adding gram iodine after overnight incubation. However, since the integration will split the amyE gene, the defective B. subtilis can no longer use starch, and no white halo can be observed after adding iodine.

Photo: Starch test for plasmid integration

3. Final Assembly:


The final recombinant DNA plasmid we get is shown in Figure above. Driven by Pveg promoter, RPMrel peptides can be highly expressed and displayed on the cell wall after fusing with the lytC displaying system. Two protein coding genes, Bmp2 and toxin ydcE are under the control of a xylose inducible promoter PxylA so that after binding, the induction of xylose can trigger the expression of both toxin and anti-tumor chemokine at the same time. Ptms, a weak constitutive promoter coupled with the antitoxin ydcD is then inserted into the same vector as well in order to limit BMP2 production through the need to maintain comparable toxin-antitoxin production rates.

Since pDG1661 contains one XbaI cutting site and three PstI cutting sites outside its multiple cloning site, inserts cannot be ligated via standard bio-brick assembly methods. Instead, we utilize vector pBluescript II KS(+) to add a BamHI cutting site after PstI and inserting all our construct through EcoRI and BamHI site.